Nishimura, N.; Kaji, K.; Nishimura, N.; Hanatani, J.; Nakatani, T.; Oyama, M.; Shibamoto, A.; Tsuji, Y.; Kitagawa, K.; Sato, S.;
et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.
https://doi.org/10.3390/ijms26146710
AMA Style
Nishimura N, Kaji K, Nishimura N, Hanatani J, Nakatani T, Oyama M, Shibamoto A, Tsuji Y, Kitagawa K, Sato S,
et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. International Journal of Molecular Sciences. 2025; 26(14):6710.
https://doi.org/10.3390/ijms26146710
Chicago/Turabian Style
Nishimura, Naoki, Kosuke Kaji, Norihisa Nishimura, Junichi Hanatani, Tatsuya Nakatani, Masafumi Oyama, Akihiko Shibamoto, Yuki Tsuji, Koh Kitagawa, Shinya Sato,
and et al. 2025. "Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis" International Journal of Molecular Sciences 26, no. 14: 6710.
https://doi.org/10.3390/ijms26146710
APA Style
Nishimura, N., Kaji, K., Nishimura, N., Hanatani, J., Nakatani, T., Oyama, M., Shibamoto, A., Tsuji, Y., Kitagawa, K., Sato, S., Namisaki, T., Tamaoki, S., & Yoshiji, H.
(2025). Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. International Journal of Molecular Sciences, 26(14), 6710.
https://doi.org/10.3390/ijms26146710
